Dr Craig Campbell is the Deputy Chair of Pediatrics (Research), the Head of the Division of Pediatric Neurology and the medical director of the multidisciplinary neuromuscular clinic based at Thames Valley Children’s Centre and the Pediatric Neurophysiology Laboratory at Children’s Hospital London Health Sciences Centre. He is an Associate Professor in Pediatrics, Clinical Neurological Sciences and Epidemiology at Western University and a Scientist at the Children’s Health Research Institute. His training in pediatrics, neurology and epidemiology was completed at the University of Ottawa.
Dr. Campbell is collaboratively involved in many academic and industry initiated clinical trial activities in pediatric neuromuscular disease. He is a member of the Muscle Study Group and the World Muscle Society, and co-chair of the TREAT-NMD Registry Oversight Committee and Task Force. Dr Campbell has been awarded the George Karpati Award Researcher of the Year in 2011 and 2015 by Muscular Dystrophy Canada.
As part of NMD4C Dr Campbell is implementing innovations for the Canadian Neuromuscular Disease Registry that facilitate data sharing and patient engagement. He will also be developing a research curriculum and clinical trial network.
McMillan, HJ, Amid, A, Gonorazky, H, Almobarak, S, Campbell, C. Drisapersen associated with elevated serum factor VIII levels in Duchenne muscular dystrophy. Neurology. 2020. PMID:32075891
Al-Qadhi, SA, Chawla, T, Seabrook, JA, Campbell, C, Burhan, AM. Competency by Design for Electroconvulsive Therapy in Psychiatry Postgraduate Training: Face and Content Validation Study. J ECT. 2020.36 (1)18-24 PMID:31990735
Johnson, NE, Aldana, EZ, Angeard, N, Ashizawa, T, Berggren, KN, Marini-Bettolo, C et al.. Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1. Neurol Clin Pract. 2019.9 (5)443-454 PMID:31750030
Wood, L, Bassez, G, Bleyenheuft, C, Campbell, C, Cossette, L, Jimenez-Moreno, AC et al.. Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease. Orphanet J Rare Dis. 2019.14 (1)199 PMID:31416449
Hunter, M, Ekstrom, AB, Campbell, C, Hung, M, Bounsanga, J, Bates, K et al.. Patient-reported study of the impact of pediatric-onset myotonic dystrophy. Muscle Nerve. 2019.60 (4)392-399 PMID:31298737
Zapata-Aldana, E, McMillan, HJ, Rupar, T, Brunel-Guitton, C, Chakraborty, P, Mitchell, JJ et al.. Muscle problems in juvenile-onset acid maltase deficiency (Pompe disease). Paediatr Child Health. 2019.24 (4)270-271 PMID:31239817
Prasad, M, Glueck, M, Ceballos-Saenz, D, Zapata-Aldana, E, Johnson, N, Campbell, C et al.. A Phenotypic Description of Congenital Myotonic Dystrophy using PhenoStacks. J Neuromuscul Dis. 2019.6 (3)341-347 PMID:31227653
Ceballos-Sáenz, D, Zapata-Aldana, E, Singeris, S, Hicks, R, Johnson, N, Campbell, C et al.. Body composition in patients with congenital myotonic dystrophy. Muscle Nerve. 2019.60 (2)176-179 PMID:31074869
El-Aloul, B, Speechley, KN, Wei, Y, Wilk, P, Campbell, C. Fatigue in young people with Duchenne muscular dystrophy. Dev Med Child Neurol. 2020.62 (2)245-251 PMID:30980541
Zapata-Aldana, E, Al-Mobarak, SB, Karp, N, Campbell, C. Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family. Am. J. Med. Genet. A. 2019.179 (6)1034-1041 PMID:30938034